Three new drugs for hyperlipidemia.
D001384:Azetidines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D000069438:Ezetimibe; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008148:Lovastatin / Q000008:administration & dosage* / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*
D001384:Azetidines; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D000960:Hypolipidemic Agents; C451780:lovastatin-niacin combination; D009525:Niacin; D008148:Lovastatin; D000069438:Ezetimibe